Sleeve denied as experimental or investigational by Cigna?

Under Cigna Medical Coverage Policy 0051, Cigna covers bariatric surgery for the treatment of morbid obesity using a covered procedure as medically necessary when ALL specified criteria are met. Sleeve gastrectomy as a stand-alone or staged procedure is included among medically necessary adult bariatric procedures (laparoscopic CPT 43775; open 43843). Adult eligibility requires the individual is ≥18 years of age or has reached full expected skeletal growth AND has evidence of a BMI ≥40, or a BMI 35–39.9 with at least one clinically significant obesity-related comorbidity, plus medical management including evidence of active participation within the last 12 months in a weight-management program supervised by a physician or registered dietician for a minimum of three consecutive months (≥89 days) with monthly documentation. Programs such as Weight Watchers, Jenny Craig, and Optifast are acceptable alternatives if done in conjunction with physician or registered dietician supervision and detailed documentation. Per AACE/ACE/TOS/ASMBS/OMA/ASA 2019 updated guidelines incorporated by Cigna, BMI thresholds are adjusted for individuals of Asian descent. For adolescents, sleeve gastrectomy and Roux-en-Y gastric bypass are the only medically necessary procedures when adolescent-specific criteria are met; all other bariatric procedures in adolescents are considered not medically necessary. Tobacco use should be avoided at all times by all patients; patients who smoke cigarettes should stop, preferably at least six weeks before bariatric surgery. Effective January 15, 2025, the policy clarifies that the coverage statement applies to "initial" surgery, and bariatric surgery for primary treatment of any condition other than morbid obesity is considered not medically necessary.

- Document BMI with serial weight measurements and list each qualifying comorbidity (T2DM, HTN, OSA, GERD, NAFLD, dyslipidemia) with ICD-10 codes; cite the AACE/ACE/TOS/ASMBS/OMA/ASA 2019 guideline endorsement, including adjusted BMI thresholds for Asian patients , which Cigna's own policy incorporates. - Submit a consolidated supervised weight-management log meeting the ≥89-day, monthly-documented, physician- or RD-supervised standard within the last 12 months ; if a commercial program was used, attach physician/RD co-signed notes per Cigna's allowance for Weight Watchers, Jenny Craig, or Optifast with clinician supervision . - Provide letters from a licensed mental health professional (psych clearance) and a registered dietitian (nutritional assessment) dated within 12 months of the request, addressing each ASMBS/AACE preoperative element. - Submit proof of smoking cessation ≥6 weeks pre-op (cotinine test, attestation, cessation program records) to address Cigna's tobacco-cessation expectation ; the 2022 ASMBS/IFSO Indications for Metabolic and Bariatric Surgery support proceeding once cessation is documented. - For Marketplace plan-exclusion denials, request the Summary Plan Description and challenge under state Essential Health Benefit benchmarks; cite the 2022 ASMBS/IFSO guideline recognizing MBS as the most effective evidence-based treatment for clinically severe obesity, supported by STAMPEDE and SLEEVEPASS RCTs showing durable benefit of sleeve gastrectomy. - For "not initial procedure" or revision denials, document the specific complication (stricture, leak, reflux, inadequate weight loss <50% EBWL) meeting Cigna's coverage of takedown for complications and revision/conversion criteria . - For facility/credentialing denials, redirect surgery to an MBSAQIP Comprehensive- or Comprehensive-with-Adolescent-accredited facility , which satisfies Cigna's 3 Star Quality / Center of Excellence requirements.

## Why Cigna Denies Sleeve Gastrectomy as Experimental

Although sleeve gastrectomy has been a mainstream, FDA-cleared bariatric procedure for well over a decade, Cigna occasionally applies an experimental or investigational denial — most often in specific clinical scenarios such as patients outside its standard eligibility criteria, adolescent patients, or when sleeve is being proposed as a revisional procedure after prior bariatric surgery. Understanding exactly which scenario triggered the experimental label is the first step in building your appeal.

## Why This Denial Is Appealable

Sleeve gastrectomy is not experimental in the mainstream sense. It is widely performed, has robust long-term outcome data in the published literature, and is endorsed by major clinical societies including the American Society for Metabolic and Bariatric Surgery and the American College of Surgeons. If Cigna's denial is based on a narrow policy exclusion for your particular clinical scenario, that exclusion must be measured against the current state of medical evidence and the applicable clinical guideline recommendations. Request Cigna's published medical coverage policy that was cited in the denial and identify the exact language used to classify your case as investigational. That language is your roadmap.

## Federal Appeal Rights

Under ERISA §503, employer-sponsored plan members are entitled to a full-and-fair internal review with access to all documents the plan relied upon. Under ACA §2719, if the internal process is exhausted, an independent external review by an accredited IRO is available. The external review window is generally around four months from the final internal denial — verify the precise deadline on your denial notice. An expedited pathway is available if waiting would seriously harm your health.

## Concrete Appeal Steps

1. Obtain the exact policy language and any clinical evidence review that Cigna used to classify sleeve gastrectomy as experimental in your case. 2. File a Level 1 internal appeal with a written rebuttal supported by your surgeon's letter. 3. If denied at Level 1, escalate to Level 2 or external review. 4. If your clinical situation is urgent, request expedited review in writing from your surgeon.

## Documentation to Gather

• A detailed medical-necessity and evidence-based letter from your bariatric surgeon addressing why sleeve gastrectomy is the appropriate, established standard of care for your specific condition.
• Your complete diagnosis and comorbidity documentation from your chart.
• Records of all prior weight-management interventions attempted, with dates and documented outcomes.
• A statement from your surgeon citing the relevant clinical society guidelines (by organization name, not specific numbers) supporting sleeve gastrectomy in your clinical scenario.

## Criteria-Mapping Framework

List each condition Cigna's policy uses to define an intervention as investigational (e.g., lack of endorsement by recognized clinical bodies, absence of peer-reviewed evidence, not generally accepted). For each condition, your rebuttal should cite the specific counter-evidence: the surgeon's letter, the relevant guideline organization's position, and your clinical chart facts. Pair every policy requirement with a corresponding documented fact.